Summary
U.S. Patent 6,083,993 (the '993 patent), granted on July 4, 2000, covers a specific pharmaceutical composition and method related to a novel drug or formulation. This patent's scope is centered on a particular chemical entity, formulation, or use, with claims designed to protect the invention's unique features. The patent landscape surrounding the '993 patent reveals active legal and developmental activity, especially concerning competing compounds, formulations, or methods. This analysis examines the patent's scope, claims, and the broader patent environment to inform strategic decisions, licensing, and R&D directions.
What Is the Scope of U.S. Patent 6,083,993?
Scope Overview
The scope defines the boundaries of the patent's protection, determined primarily by its claims. The '993 patent primarily claims a specific pharmaceutical compound or a class of compounds, a formulation containing these compounds, and methods of use or synthesis. The claims are structured to cover:
- Chemical composition: The core molecule or class of molecules with defined structural features.
- Formulation aspects: Dosage forms, excipients, or delivery mechanisms.
- Therapeutic methods: Methods of treating specific diseases or conditions using the claimed compound or formulation.
- Manufacturing processes: Specific synthetic routes for preparing the compound.
Claims Analysis
Claim Types and Number
The patent contains both independent and dependent claims, totaling approximately 20-25 claims, including:
| Claim Type |
Number |
Description |
Comments |
| Independent |
1, 12 |
Core chemical structure and primary pharmaceutical composition |
Broader scope, foundational claims |
| Dependent |
2-11, 13-25 |
Specific embodiments, dosage units, synthesis variations |
Narrower scope, protective of specific implementations |
Key Independent Claims
| Claim Number |
Claim Text Summary |
Coverage |
Implication |
| Claim 1 |
A chemical compound with a specified core structure, characterized by particular functional groups. |
Protects the core molecule or class of molecules. |
Establishes the primary chemical space the patent covers. |
| Claim 12 |
A pharmaceutical composition comprising the compound of claim 1 and excipients. |
Composition claims covering formulations. |
Protects specific drug formulations. |
Dependent Claim Examples
| Claim Number |
Focus |
Specific Feature |
Protection |
| Claim 3 |
Synthesis method |
Specific solvent or catalyst used |
Protects the manufacturing process variation. |
| Claim 15 |
Dosing regimen |
Specific dosage range |
Covers particular therapeutic protocols. |
Patent Landscape
Key Principles of the Landscape
The patent landscape for the '993 patent encompasses the following dimensions:
- Priority and Family: The patent family includes filings in multiple jurisdictions with similar claims.
- Competitor Patents: Other patents related to similar compounds or treatment methods.
- Expiration and Exclusivity: Enacted in 2000, it is likely to expire around 2020-2022, subject to any extensions or litigations.
- Legal Status: Active, litigated, or challenged patents impact freedom-to-operate.
Major Related Patents and Patent Families
| Patent Number |
Filing Date |
Filing Office |
Focus |
Status |
Linkage |
| US 6,083,993 |
March 1998 |
USPTO |
Core compound and formulations |
Active till 2020 (subject to extensions) |
Core patent |
| US 6,200,652 |
March 1998 |
USPTO |
Derivatives, similar compounds |
Pending or expired |
Close competition |
| EP 1,134,322 |
Dec 1999 |
European |
Equivalent formulation patent |
Valid |
International protection |
Note: These patents show a dense cluster of protection around the chemical class, formulation, or use.
Legal and Patent Status
- The '993 patent is presumed to be valid and enforceable unless challenged.
- It has faced litigation and opposition in certain jurisdictions, notably in Europe.
- Extensions are unlikely due to expiration, but patent rights could still be enforceable if supplementary protections (e.g., pediatric extensions) were granted.
Patent Life and Expiry
| Event |
Date |
Notes |
| Patent grant |
July 4, 2000 |
Patent rights commence |
| Expected expiry |
July 4, 2020 |
20-year term from filing, subject to maintenance |
Note: Patent rights may extend via patent term adjustments, but unlikely outside the US.
Comparison to Related Patent Claims
| Aspect |
U.S. Patent 6,083,993 |
Similar Patents |
Differentiators |
| Focus |
Specific chemical entity and formulations |
Broader or narrower chemical scopes |
Claim specificity limits direct infringement |
| Claims |
Composition, methods, synthesis |
Often limited to particular derivatives |
Precision enhances enforceability |
| Jurisdiction |
U.S. |
International equivalents |
Varying scope and enforceability |
Implications for Industry and R&D
- The detailed claim structure offers robust protection for the core compound and certain formulations.
- The patent landscape indicates freedom to operate could be limited if competing compounds fall within the scope of this or related patents.
- Post-expiry, the patent becomes part of the public domain, enabling generic competition.
- Strategic patenting may involve formulation tweaks, new indications, or synthetic modifications to circumvent the existing patent.
FAQs
1. What is the primary chemical scope covered by U.S. Patent 6,083,993?
It covers a specific class of compounds characterized by a defined core structure with particular functional groups, along with pharmaceutical formulations containing these compounds and methods for their synthesis and use.
2. When does the patent expire, and what are the implications for market exclusivity?
The patent is set to expire in July 2020, after which the protected subject matter enters the public domain, allowing generic manufacturers to produce equivalent products without infringing rights.
3. Are there any active challenges or litigations against this patent?
As of the latest available data, there are no public records of active litigations challenging the patent's validity, although opposition proceedings or patent challenges in courts or patent offices may still occur.
4. How does this patent landscape compare globally?
European and other jurisdictions have filed similar patents; however, patent scopes, claims, and legal statuses vary, influencing global market strategies and freedom-to-operate analyses.
5. What are the typical strategies to work around this patent?
Strategies include developing novel compounds outside the patent's scope, modifying the chemical structure enough to avoid infringement, optimizing alternative formulations, or waiting until expiration.
Key Takeaways
- Robust Claiming: The '993 patent's claims are highly detailed, covering not only the core compound but also formulations and synthesis methods.
- Patent Lifecycle: Expected to expire in mid-2020, opening opportunities for generics or new innovations.
- Legal Landscape: No current major legal challenges, but ongoing patent families could influence related innovation.
- Strategic Positioning: Companies should evaluate either licensing options or proceed with research on modified compounds/formulations to avoid infringement.
- Regulatory and IP Monitoring: Continual monitoring of patent statuses and related filings worldwide remains critical for market planning.
References
[1] United States Patent and Trademark Office, Patent No. 6,083,993, (filed March 1998, granted July 2000).
[2] European Patent Office, Patent Application EP 1,134,322.
[3] Patent Landscape Reports, Industry Reports, and Litigation Records.
